Sign in
Taking peopleNo phase

Tests an early lipid-lowering care program after heart-related hospital stays

Tests an early cholesterol-lowering support program in adults with heart disease in Asia-Pacific.

Key facts

Who runs it
Stephen Nicholls
Where
Bangkok, Khon Kaen, and Songkhla, ThailandSee the 3 sitesAlso in 8 other countries, 19 sites
Trial code
Registry title
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Status
Recruiting
People taking part
2,000 people, planned
Started
15 Sept 2022
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Early Intervention
Record updated
8 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who were admitted to hospital with a Type I heart attack (myocardial infarction). It tests a multi-part programme to lower cholesterol.

Age
18 years or older
Sex
Men and women can join.
Disease stage
Admission to hospital for a Type I myocardial infarction (heart attack).
Biomarker or test result
LDL cholesterol must not be below 1.4mmol/L (54 mg/dL) at the start.

Main reasons for not taking part

  • LDL below 1.4mmol/L (54 mg/dL) at baseline
  • Cannot give contact details of their primary care doctor or general practitioner
  • Cannot give written informed consent
  • Unlikely to survive more than 12 months

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • 18 years of age
  • Admission for Type I myocardial infarction

Who cannot take part

  • LDL <1.4mmol/L at baseline
  • Unable to provide contact details of primary care physician/general practitioner
  • Unable to provide written informed consent
  • Unlikely to survive >12 months

Where in Thailand

Also in 8 other countries, 19 sites

  • Siriraj HospitalBangkok, ThailandContact: Rungroj KrittayaphongNot yet recruiting
  • Srinagarind Hospital and Queen Sirikit Heart Center of the NortheastKhon Kaen, ThailandContact: Burabha PussadhammaNot yet recruiting
  • Songklanagarind HospitalSongkhla, ThailandContact: Ply ChichareonNot yet recruiting

About the trial

What the trial wants to find out

Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study.

Read full original descriptionShow less

Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.

The 2 groups in the trial

  • Early interventionExisting treatment, for comparison

    Participants randomised to 'early' will receive the intervention at baseline through 6 months. while those randomised to 'late' will receive standard-of-care and represent a control arm over this period.

  • Late interventionOther group

    Those randomised to 'late' will receive standard-of-care and represent a control arm to the early intervention group.

    Treatment: Early Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific (GOAL-ASIA)
Plain-language title
Tests an early lipid-lowering care program after heart-related hospital staysGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
8 October 2026